MedTrace Logo

Turkish Adaptation of the CTS-6 Evaluation Tool: A Validation and Reliability Study

NCT07420049 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 126

Last updated 2026-07-30

No results posted yet for this study

Summary

The purpose of this study is to develop the Turkish version of the CTS-6 Evaluation Tool and to comprehensively assess its validity and reliability in the Turkish population. The CTS-6 Evaluation Tool is a widely used and reliable instrument for the assessment of diagnosis and symptom severity in patients with carpal tunnel syndrome.

In this study, the CTS-6 will undergo translation and cultural adaptation to ensure linguistic and cultural appropriateness for the Turkish population. The goal is to produce a valid, reliable, and practical tool that can be used efficiently in clinical settings. The adapted version is intended to be applicable across multiple medical specialties involved in the diagnosis and management of carpal tunnel syndrome in Turkey. The results are expected to provide a trustworthy Turkish version of the CTS-6 suitable for both clinical practice and research purposes.

Conditions

  • Carpal Tunnel Syndrome (CTS)
  • Median Nerve Entrapment
  • Peripheral Nerve Disease
  • Peripheral Nerve Disorder
  • Reliability and Validity
  • Cross-cultural Adaptation
  • TURKISH VALIDITY AND RELIABILITY STUDY OF CTS-6 EVALUATİON TOOL
  • Diagnostic Tool

Interventions

DIAGNOSTIC_TEST

CTS-6 Evaluation Tool

In this study, we aim to develop the Turkish version of the CTS-6 Evaluation Tool and to evaluate the validity and reliability of this version.

Sponsors & Collaborators

  • Istanbul University

    lead OTHER

Principal Investigators

  • Sina Arman (Esmailzadeh) · Istanbul Unıversity Istanbul Medicine Faculty

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-01
Primary Completion
2026-07-29
Completion
2026-07-29

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07420049 on ClinicalTrials.gov